Touchstone Plays Tough As IP Group Ups Bid To £490m

One of the key attractions is Touchstone's holdings in Imperial College spin-offs such as Cell Medica, Circassia Pharmaceuticals and TopiVert Pharma.

Light bulb
IP Group keen on innovation in Touchstone portfolio

A number of UK biotech start-ups and university researchers are watching with interest a revised takeover offer from IP Group to merge with fellow intellectual property group Touchstone Innovations.

The revised all-share offer, worth in the region of £490m, values each Touchstone share at 304p, a premium of around 11% to the latter's closing price of 273.6 pence on July 17

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business